Bangolo, A.; Amoozgar, B.; Zhang, L.; Nagesh, V.K.; Sekhon, I.; Weissman, S.; Vesole, D.; Phull, P.; Donato, M.; Biran, N.;
et al. Impact of Allogeneic Stem Cell Transplant on Safety and Outcomes of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Patients with Multiple Myeloma (MM). J. Clin. Med. 2024, 13, 6207.
https://doi.org/10.3390/jcm13206207
AMA Style
Bangolo A, Amoozgar B, Zhang L, Nagesh VK, Sekhon I, Weissman S, Vesole D, Phull P, Donato M, Biran N,
et al. Impact of Allogeneic Stem Cell Transplant on Safety and Outcomes of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Patients with Multiple Myeloma (MM). Journal of Clinical Medicine. 2024; 13(20):6207.
https://doi.org/10.3390/jcm13206207
Chicago/Turabian Style
Bangolo, Ayrton, Behzad Amoozgar, Lili Zhang, Vignesh K. Nagesh, Imranjot Sekhon, Simcha Weissman, David Vesole, Pooja Phull, Michele Donato, Noa Biran,
and et al. 2024. "Impact of Allogeneic Stem Cell Transplant on Safety and Outcomes of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Patients with Multiple Myeloma (MM)" Journal of Clinical Medicine 13, no. 20: 6207.
https://doi.org/10.3390/jcm13206207
APA Style
Bangolo, A., Amoozgar, B., Zhang, L., Nagesh, V. K., Sekhon, I., Weissman, S., Vesole, D., Phull, P., Donato, M., Biran, N., Siegel, D., & Parmar, H.
(2024). Impact of Allogeneic Stem Cell Transplant on Safety and Outcomes of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Patients with Multiple Myeloma (MM). Journal of Clinical Medicine, 13(20), 6207.
https://doi.org/10.3390/jcm13206207
